catherine s adamson
机构: University of St Andrews
每年引用次数
引用次数
引用: 2,108
H-指数: 23
I10-指数 : 29
出版物: 50
Antiviral drug discovery: preparing for the next pandemic.
Marcel Jaspars , Kelly Chibale , Rosemary A Dorrington , David J Newman
Chemical Society Reviews 50 ( 6) 3647 -3655
100
2021
Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV- 1maturation inhibitor bevirimat
Catherine S Adamson , Michael Sakalian , Karl Salzwedel , Eric O Freed
Retrovirology 7 ( 1) 36 -36
69
2010
Green fluorescent protein as a reporter of prion protein folding.
Snezana Vasiljevic , Junyuan Ren , YongXiu Yao , Kevin Dalton
Virology Journal 3 ( 1) 59 -59
20
2006
Virus maturation as a new HIV-1 therapeutic target.
Catherine S Adamson , Karl Salzwedel , Eric O Freed
Expert Opinion on Therapeutic Targets 13 ( 8) 895 -908
58
2009
Control of human immunodeficiency virus type-1 protease activity in insect cells expressing Gag-Pol rescues assembly of immature but not mature virus-like particles.
Catherine S Adamson , Milan Nermut , Ian M Jones
Virology 308 ( 1) 157 -165
12
2003
A block in virus-like particle maturation following assembly of murine leukaemia virus in insect cells.
Catherine S Adamson , Adam Davies , Yuko Soneoka , Milan Nermut
Virology 314 ( 2) 488 -496
7
2003
Far-UVC (222 nm) efficiently inactivates an airborne pathogen in a room-sized chamber
Ewan Eadie , Waseem Hiwar , Louise Fletcher , Emma Tidswell
Scientific reports 12 ( 1) 4373
27
2022
Research Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV-1maturation inhibitor bevirimat
Catherine S Adamson , Michael Sakalian , Karl Salzwedel , Eric O Freed
2010
279 Whither antibacterial drug discovery?
Gergely Szakács , András Váradi , Csilla Özvegy-Laczka , Balázs Sarkadi
Specificity and sensitivity of an RNA targeting type III CRISPR complex coupled with a NucC endonuclease effector
Sabine Grüschow , Catherine S Adamson , Malcolm F White
Nucleic acids research 49 ( 22) 13122 -13134
45
2021
rsc. li/chem-soc-rev
Nicolai Lehnert , Bradley W Musselman , Lance C Seefeldt , Catherine S Adamson
Chem. Soc. Rev 50 3656 -3656
2021
Antiviral drug discovery: preparing for the next pandemic [Erratum: August 2021, Vol. 50 (16), p. 9346]
Catherine S Adamson , Kelly Chibale , Rebecca JM Goss , Marcel Jaspars
2021
Far-UVC efficiently inactivates an airborne pathogen in a room-sized chamber
Ewan Eadie , Waseem Hiwar , Louise Fletcher , Emma Tidswell
3
2021
The role of ion dissolution in metal and metal oxide surface inactivation of SARS-CoV-2
Jane Hilton , Yoshiko Nanao , Machiel Flokstra , Meisam Askari
Applied and Environmental Microbiology 90 ( 2) e01553 -23
2024
Modular cell-based platform for high throughput identification of compounds that inhibit a viral interferon antagonist of choice.
Andri Vasou , Christina Paulus , Janina Narloch , Zoe O Gage
Antiviral Research 150 79 -92
8
2018
The quest for COVID-19 treatments
Jane Victoria Hilton , Catherine S Adamson
Microbiology Today
2
2021
Gene structure and expression-Cloning and characterization of hIF2, a human homologue of bacterial translation initiation factor 2 and its interaction with HIV-1 matrix
SA Wilson , C Sieiro-Vazquez , NJ Edwards , O Iourin
Biochemical Journal 342 ( 1) 97 -104
1999
Parameters influencing measurement of the Gag antigen-specific T-proliferative response to HIV type 1 infection.
Daryl S. Schiller , James M. Binley , Kenneth H. Roux , Catherine S. Adamson
AIDS Research and Human Retroviruses 16 ( 3) 259 -271
12
2000
Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function.
Catherine S. Adamson , Michael M. Nevels
Viruses 12 ( 1) 110
12
2020
Antiviral Agents: Discovery to Resistance.
Catherine S. Adamson
Viruses 12 ( 4) 406 -406
4
2020